SignatureFD
ASND icon

SignatureFD’s Ascendis Pharma A/S ASND Stock Holding History

SignatureFD’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$167K Buy
734
+7
+1% +$1.77K ﹤0.01% 1274
2026
Q2 		$194K Buy
727
+27
+4% +$6.31K ﹤0.01% 1112
2026
Q1 		$160K Buy
700
+10
+1% +$2.24K ﹤0.01% 1114
2025
Q4 		$147K Buy
690
+8
+1% +$1.65K ﹤0.01% 1131
2025
Q3 		$136K Buy
682
+25
+4% +$4.66K ﹤0.01% 1136
2025
Q2 		$113K Buy
657
+17
+3% +$2.77K ﹤0.01% 1186
2025
Q1 		$100K Sell
640
-52
-8% -$7.43K ﹤0.01% 1215
2024
Q4 		$95.3K Buy
692
+6
+0.9% +$789 ﹤0.01% 1253
2024
Q3 		$102K Buy
686
+80
+13% +$10.8K ﹤0.01% 1207
2024
Q2 		$82.6K Sell
606
-46
-7% -$6.26K ﹤0.01% 1272
2024
Q1 		$98.6K Buy
652
+89
+16% +$12.7K ﹤0.01% 1198
2023
Q4 		$70.9K Sell
563
-235
-29% -$23.4K ﹤0.01% 1300
2023
Q3 		$74.7K Buy
798
+193
+32% +$18.1K ﹤0.01% 1203
2023
Q2 		$54K Sell
605
-672
-53% -$58.5K ﹤0.01% 1382
2023
Q1 		$137K Sell
1,277
-64
-5% -$7.32K ﹤0.01% 879
2022
Q4 		$164K Buy
1,341
+49
+4% +$5.69K ﹤0.01% 780
2022
Q3 		$133K Buy
1,292
+500
+63% +$47.4K ﹤0.01% 821
2022
Q2 		$74K Buy
792
+529
+201% +$49.9K ﹤0.01% 1112
2022
Q1 		$31K Sell
263
-393
-60% -$45.5K ﹤0.01% 1609
2021
Q4 		$88K Sell
656
-2
-0.3% -$297 ﹤0.01% 1079
2021
Q3 		$105K Buy
658
+176
+37% +$24.1K ﹤0.01% 946
2021
Q2 		$63K Buy
482
+125
+35% +$16.7K ﹤0.01% 1162
2021
Q1 		$46K Buy
357
+74
+26% +$11.2K ﹤0.01% 1203
2020
Q4 		$47K Buy
283
+61
+27% +$10.1K ﹤0.01% 1108
2020
Q3 		$34K Buy
222
+147
+196% +$21.1K ﹤0.01% 1139
2020
Q2 		$11K Buy
75
+43
+134% +$5.9K ﹤0.01% 1529
2020
Q1 		$4K Buy
+32
New +$4.16K ﹤0.01% 1718

Other funds holding ASND

Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Henry James International Management
Henry James International Management New York $330M AUM 35.5% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return

SignatureFD's ASND Position: Q3 2026 in Review

SignatureFD increased its Ascendis Pharma A/S (ASND) stake by 0.96% in Q3 2026, buying an estimated $1.77K and bringing the position to 734 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

SignatureFD first reported a position in ASND in Q1 2020 and has held it in 27 quarters since. The position peaked at $194K in Q2 2026. 48 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • SignatureFD held 734 shares of Ascendis Pharma A/S worth $167K as of Q3 2026.
  • SignatureFD bought 7 Ascendis Pharma A/S shares in Q3 2026, an estimated $1.77K.
  • Ascendis Pharma A/S made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1274 holding.
  • SignatureFD first reported a position in Ascendis Pharma A/S in Q1 2020 and has held it in 27 quarters since.
  • SignatureFD's Ascendis Pharma A/S position peaked at $194K in Q2 2026.
  • 48 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.